Kodiak Sciences Inc.

For the period ended Jun 30, 2026. Filed Aug 13, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 13, 2026

KOD$107.10+7.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

Condensed Consolidated Balance Sheets (unaudited)

(in thousands, except share and per share amounts)

	June 30,2026	December 31,2025
Assets
Current assets:
Cash and cash equivalents	$125,903	$209,862
Prepaid expenses and other current assets	5,455	4,954
Total current assets	131,358	214,816
Restricted cash	6,184	6,184
Property and equipment, net	78,308	85,258
Operating lease right-of-use asset	32,299	36,606
Other assets	8,662	8,669
Total assets	$256,811	$351,533
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$12,639	$12,863
Accrued and other current liabilities	30,320	20,607
Operating lease liability	9,811	12,063
Total current liabilities	52,770	45,533
Long-term operating lease liability	42,945	47,117
Liability related to sale of future royalties	100,000	100,000
Long-term deposit	—	1,500
Total liabilities	195,715	194,150
Commitments and contingencies (Note 5)
Stockholders’ equity:
Preferred stock, $0.0001 par value – 10,000,000 shares authorized;none issued	—	—
Common stock, $0.0001 par value – 490,000,000 shares authorized;62,830,860 and 61,758,454 shares issued and outstanding, respectively	6	6
Additional paid-in capital	1,743,596	1,716,082
Accumulated deficit	(1,682,506)	(1,558,705)
Total stockholders’ equity	61,096	157,383
Total liabilities and stockholders’ equity	$256,811	$351,533

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.